DOCGO INC (DCGO) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:DCGO • US2560861096

0.7181 USD
-0.06 (-7.59%)
At close: Feb 3, 2026
0.72 USD
+0 (+0.26%)
After Hours: 2/3/2026, 8:09:55 PM
Fundamental Rating

3

Overall DCGO gets a fundamental rating of 3 out of 10. We evaluated DCGO against 102 industry peers in the Health Care Providers & Services industry. No worries on liquidiy or solvency for DCGO as it has an excellent financial health rating, but there are worries on the profitability. DCGO has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year DCGO has reported negative net income.
  • In the past year DCGO had a positive cash flow from operations.
  • DCGO had positive earnings in 4 of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: DCGO reported negative operating cash flow in multiple years.
DCGO Yearly Net Income VS EBIT VS OCF VS FCFDCGO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

  • DCGO's Return On Assets of -14.58% is on the low side compared to the rest of the industry. DCGO is outperformed by 77.45% of its industry peers.
  • The Return On Equity of DCGO (-19.07%) is worse than 64.71% of its industry peers.
Industry RankSector Rank
ROA -14.58%
ROE -19.07%
ROIC N/A
ROA(3y)4.86%
ROA(5y)1.57%
ROE(3y)7.06%
ROE(5y)1.16%
ROIC(3y)N/A
ROIC(5y)N/A
DCGO Yearly ROA, ROE, ROICDCGO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

  • DCGO's Profit Margin has declined in the last couple of years.
  • In the last couple of years the Operating Margin of DCGO has declined.
  • DCGO's Gross Margin of 31.21% is fine compared to the rest of the industry. DCGO outperforms 60.78% of its industry peers.
  • In the last couple of years the Gross Margin of DCGO has remained more or less at the same level.
  • DCGO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 31.21%
OM growth 3Y-8.41%
OM growth 5YN/A
PM growth 3Y-24.17%
PM growth 5YN/A
GM growth 3Y0.21%
GM growth 5YN/A
DCGO Yearly Profit, Operating, Gross MarginsDCGO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

More info and screens

7

2. Health

2.1 Basic Checks

  • DCGO does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • DCGO has less shares outstanding than it did 1 year ago.
  • Compared to 1 year ago, DCGO has a worse debt to assets ratio.
DCGO Yearly Shares OutstandingDCGO Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
DCGO Yearly Total Debt VS Total AssetsDCGO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

  • DCGO has an Altman-Z score of 1.19. This is a bad value and indicates that DCGO is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of 1.19, DCGO is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
  • The Debt to FCF ratio of DCGO is 0.32, which is an excellent value as it means it would take DCGO, only 0.32 years of fcf income to pay off all of its debts.
  • With an excellent Debt to FCF ratio value of 0.32, DCGO belongs to the best of the industry, outperforming 93.14% of the companies in the same industry.
  • A Debt/Equity ratio of 0.04 indicates that DCGO is not too dependend on debt financing.
  • DCGO has a Debt to Equity ratio of 0.04. This is amongst the best in the industry. DCGO outperforms 80.39% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.32
Altman-Z 1.19
ROIC/WACCN/A
WACC8.54%
DCGO Yearly LT Debt VS Equity VS FCFDCGO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 2.59 indicates that DCGO has no problem at all paying its short term obligations.
  • DCGO has a Current ratio of 2.59. This is amongst the best in the industry. DCGO outperforms 81.37% of its industry peers.
  • A Quick Ratio of 2.59 indicates that DCGO has no problem at all paying its short term obligations.
  • The Quick ratio of DCGO (2.59) is better than 81.37% of its industry peers.
Industry RankSector Rank
Current Ratio 2.59
Quick Ratio 2.59
DCGO Yearly Current Assets VS Current LiabilitesDCGO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

2

3. Growth

3.1 Past

  • DCGO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -194.14%.
  • DCGO shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -9.93% yearly.
  • The Revenue for DCGO has decreased by -47.03% in the past year. This is quite bad
  • The Revenue has been growing by 24.60% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-194.14%
EPS 3Y-9.93%
EPS 5YN/A
EPS Q2Q%-326%
Revenue 1Y (TTM)-47.03%
Revenue growth 3Y24.6%
Revenue growth 5YN/A
Sales Q2Q%-48.94%

3.2 Future

  • The Earnings Per Share is expected to decrease by -42.21% on average over the next years. This is quite bad
  • Based on estimates for the next years, DCGO will show a very negative growth in Revenue. The Revenue will decrease by -20.20% on average per year.
EPS Next Y-311.85%
EPS Next 2Y-83.02%
EPS Next 3Y-42.21%
EPS Next 5YN/A
Revenue Next Year-49.19%
Revenue Next 2Y-31.73%
Revenue Next 3Y-20.2%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DCGO Yearly Revenue VS EstimatesDCGO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
DCGO Yearly EPS VS EstimatesDCGO Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 -0.4

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

  • DCGO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year DCGO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DCGO Price Earnings VS Forward Price EarningsDCGO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

  • 100.00% of the companies in the same industry are more expensive than DCGO, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 1.36
EV/EBITDA N/A
DCGO Per share dataDCGO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

  • A cheap valuation may be justified as DCGO's earnings are expected to decrease with -42.21% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-83.02%
EPS Next 3Y-42.21%

More info and screens

0

5. Dividend

5.1 Amount

  • DCGO does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

DOCGO INC

NASDAQ:DCGO (2/3/2026, 8:09:55 PM)

After market: 0.72 +0 (+0.26%)

0.7181

-0.06 (-7.59%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-10
Earnings (Next)02-25
Inst Owners50.6%
Inst Owner Change-0.91%
Ins Owners9.01%
Ins Owner Change14.71%
Market Cap70.24M
Revenue(TTM)368.09M
Net Income(TTM)-51.59M
Analysts78.46
Price Target2.55 (255.1%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-5.06%
Min EPS beat(2)-14.37%
Max EPS beat(2)4.26%
EPS beat(4)1
Avg EPS beat(4)-85.28%
Min EPS beat(4)-311.74%
Max EPS beat(4)4.26%
EPS beat(8)3
Avg EPS beat(8)-44.96%
EPS beat(12)4
Avg EPS beat(12)-60.37%
EPS beat(16)7
Avg EPS beat(16)32.87%
Revenue beat(2)1
Avg Revenue beat(2)0.57%
Min Revenue beat(2)-0.5%
Max Revenue beat(2)1.64%
Revenue beat(4)1
Avg Revenue beat(4)-4.25%
Min Revenue beat(4)-9.68%
Max Revenue beat(4)1.64%
Revenue beat(8)3
Avg Revenue beat(8)-2.27%
Revenue beat(12)6
Avg Revenue beat(12)0.87%
Revenue beat(16)10
Avg Revenue beat(16)15.35%
PT rev (1m)-9.09%
PT rev (3m)-18.7%
EPS NQ rev (1m)-2.56%
EPS NQ rev (3m)-26.13%
EPS NY rev (1m)0%
EPS NY rev (3m)-21.62%
Revenue NQ rev (1m)0.3%
Revenue NQ rev (3m)-1.4%
Revenue NY rev (1m)0.06%
Revenue NY rev (3m)-0.11%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.19
P/FCF 1.36
P/OCF 1.22
P/B 0.26
P/tB 0.33
EV/EBITDA N/A
EPS(TTM)-0.27
EYN/A
EPS(NY)-0.35
Fwd EYN/A
FCF(TTM)0.53
FCFY73.8%
OCF(TTM)0.59
OCFY82.3%
SpS3.76
BVpS2.77
TBVpS2.16
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -14.58%
ROE -19.07%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 31.21%
FCFM 14.08%
ROA(3y)4.86%
ROA(5y)1.57%
ROE(3y)7.06%
ROE(5y)1.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.11%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-8.41%
OM growth 5YN/A
PM growth 3Y-24.17%
PM growth 5YN/A
GM growth 3Y0.21%
GM growth 5YN/A
F-Score4
Asset Turnover1.04
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.32
Debt/EBITDA N/A
Cap/Depr 39.73%
Cap/Sales 1.62%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.59
Quick Ratio 2.59
Altman-Z 1.19
F-Score4
WACC8.54%
ROIC/WACCN/A
Cap/Depr(3y)50.15%
Cap/Depr(5y)71.98%
Cap/Sales(3y)1.27%
Cap/Sales(5y)2.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-194.14%
EPS 3Y-9.93%
EPS 5YN/A
EPS Q2Q%-326%
EPS Next Y-311.85%
EPS Next 2Y-83.02%
EPS Next 3Y-42.21%
EPS Next 5YN/A
Revenue 1Y (TTM)-47.03%
Revenue growth 3Y24.6%
Revenue growth 5YN/A
Sales Q2Q%-48.94%
Revenue Next Year-49.19%
Revenue Next 2Y-31.73%
Revenue Next 3Y-20.2%
Revenue Next 5YN/A
EBIT growth 1Y-223.09%
EBIT growth 3Y14.13%
EBIT growth 5YN/A
EBIT Next Year-161.07%
EBIT Next 3Y-28.18%
EBIT Next 5YN/A
FCF growth 1Y168.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y186.23%
OCF growth 3YN/A
OCF growth 5YN/A

DOCGO INC / DCGO FAQ

What is the fundamental rating for DCGO stock?

ChartMill assigns a fundamental rating of 3 / 10 to DCGO.


What is the valuation status of DOCGO INC (DCGO) stock?

ChartMill assigns a valuation rating of 2 / 10 to DOCGO INC (DCGO). This can be considered as Overvalued.


How profitable is DOCGO INC (DCGO) stock?

DOCGO INC (DCGO) has a profitability rating of 2 / 10.


What is the financial health of DOCGO INC (DCGO) stock?

The financial health rating of DOCGO INC (DCGO) is 7 / 10.